BiotechTube
Home/CARsgen Therapeutics/Ms. Helen Yang
MH

Ms. Helen Yang

Chief Financial Officer

CARsgen Therapeutics

Therapeutic Areas

OncologySolid Tumors

CARsgen Therapeutics Pipeline

DrugIndicationPhase
CT041Gastric/Gastroesophageal Junction Adenocarcinoma, Pancreatic CancerPhase III
CT011Hepatocellular CarcinomaPhase II
CT053Relapsed/Refractory Multiple MyelomaPhase Ib/II
CT018B-cell Non-Hodgkin LymphomaPhase I
CT059Relapsed/Refractory Multiple MyelomaPhase I
CT017B-cell Non-Hodgkin LymphomaPhase I

Leadership Team at CARsgen Therapeutics

DZ
Dr. Zonghai Li
Founder, Chief Executive Officer, Chief Scientific Officer
DR
Dr. Raffaele Baffa
Chief Medical Officer
DN
Dr. Nisha Nanda
Chief Development Officer
MR
Mr. Richard Daly
CEO, CARsgen Therapeutics Corporation (U.S.)
View full CARsgen Therapeutics profile